NCT00410007

Brief Summary

The aim of the study is to test the following hypotheses:

  1. 1.that the function and/or regulation of AQP2 and /or ENaC in the principal cells is abnormal in autosomal dominant polycystic kidney disease.
  2. 2.if an abnormal function of the principal cells is present in autosomal dominant polycystic kidney disease, this will become more pronounced at high and low sodium intake.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
29

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2006

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2006

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 10, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 12, 2006

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2010

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2011

Completed
Last Updated

March 20, 2018

Status Verified

March 1, 2018

Enrollment Period

4 years

First QC Date

December 10, 2006

Last Update Submit

March 16, 2018

Conditions

Keywords

ADPKDUrinary Aquaporin-2ENaCFractional sodium excretionHigh/low sodium diet

Outcome Measures

Primary Outcomes (1)

  • u-AQP-2CR

    Urinary Aquaporin-2 corrected for creatinine

    Before and after hypertonic saline infusion after 4 days on high and low sodium diet, respectively.

Secondary Outcomes (8)

  • u-ENaC (beta)CR

    Before and after hypertonic saline infusion after 4 days on high and low sodium diet, respectively.

  • FENa

    Before and after hypertonic saline infusion after 4 days on high and low sodium diet, respectively.

  • CH2O

    Before and after hypertonic saline infusion after 4 days on high and low sodium diet, respectively.

  • u-cAMP

    Before and after hypertonic saline infusion after 4 days on high and low sodium diet, respectively.

  • uPGE-2

    Before and after hypertonic saline infusion after 4 days on high and low sodium diet, respectively.

  • +3 more secondary outcomes

Study Arms (4)

Patients with ADPKD, HS

OTHER

Each subject was studied on 2 separate days at least 3 weeks apart. During 4 days before the study day, the subjects consumed either a high sodium diet or a low sodium diet in randomized order (HS-LS/ LS-HS). On the study day a hypertonic saline infusion was given.

Behavioral: High Sodium DietBehavioral: Hypertonic saline infusion

Patients with ADPKD, LS

OTHER

Each subject was studied on 2 separate days at least 3 weeks apart. During 4 days before the study day, the subjects consumed either a high sodium diet or a low sodium diet in randomized order (HS-LS/ LS-HS). On the study day a hypertonic saline infusion was given.

Behavioral: Low Sodium DietBehavioral: Hypertonic saline infusion

Healthy Control Subjects, HS

OTHER

Each subject was studied on 2 separate days at least 3 weeks apart. During 4 days before the study day, the subjects consumed either a high sodium diet or a low sodium diet in randomized order (HS-LS/ LS-HS). On the study day a hypertonic saline infusion was given.

Behavioral: High Sodium DietBehavioral: Hypertonic saline infusion

Healthy Control Subjects, LS

OTHER

Each subject was studied on 2 separate days at least 3 weeks apart. During 4 days before the study day, the subjects consumed either a high sodium diet or a low sodium diet in randomized order (HS-LS/ LS-HS). On the study day a hypertonic saline infusion was given.

Behavioral: Low Sodium DietBehavioral: Hypertonic saline infusion

Interventions

250-350 mmol

Healthy Control Subjects, HSPatients with ADPKD, HS
Low Sodium DietBEHAVIORAL

25-35 mmol

Healthy Control Subjects, LSPatients with ADPKD, LS

7 ml/ kg of 3% saline were given over 30 minutes.

Healthy Control Subjects, HSHealthy Control Subjects, LSPatients with ADPKD, HSPatients with ADPKD, LS

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Caucasian men and women
  • age 18-65 years
  • BMI between 18,5-30,0 kg/m2
  • ADPKD, diagnosed by the following findings on ultra scan:
  • for patients without ADPKD family history: \> 5 bilateral cysts
  • for patients with ADPKD family history: \< 30 years: 2 cysts (unilateral or bilateral) 30-60 years: 2 or more bilateral cysts \> 60 years: 4 or more bilateral cysts
  • Kidney function: stadium 1-4.

You may not qualify if:

  • Other kidney disease
  • Anamnestic or clinical signs of acute myocardial infarction, atrial fibrillation, heart valve disease or chronic heart failure
  • Anamnestic or clinical signs of disease in lungs, liver,endocrine organs or brain or neoplastic disease
  • Family history of rupture of intracerebral aneurisms
  • Alcohol or drug abuse
  • Smoking
  • Medical treatment arat form antihypertensives and oral anticonceptives
  • Pregnancy or breastfeeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Medical Research, Holstebro Hospital

Holstebro, 7500, Denmark

Location

MeSH Terms

Conditions

Polycystic Kidney, Autosomal Dominant

Interventions

Diet, Sodium-Restricted

Condition Hierarchy (Ancestors)

Polycystic Kidney DiseasesKidney Diseases, CysticKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesAbnormalities, MultipleCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesCiliopathiesGenetic Diseases, Inborn

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Erling B. Pedersen, Professor

    Department of Medical Research, Holstebro Hospital, Denmark

    STUDY CHAIR
  • Carolina C. Graffe, MD

    Department of Medical Research, Holstebro Hospital, Denmark

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator, PhD, MD

Study Record Dates

First Submitted

December 10, 2006

First Posted

December 12, 2006

Study Start

October 1, 2006

Primary Completion

October 1, 2010

Study Completion

November 1, 2011

Last Updated

March 20, 2018

Record last verified: 2018-03

Locations